期刊文献+

肌肉注射脐带间充质干细胞对扩张型心肌病大鼠相关细胞因子的影响 被引量:5

Human umbilical cord mesenchymal stem cells via intramuscular injection influence the expression of cytokines related to dilated cardiomyopathy in rats
下载PDF
导出
摘要 背景:已有研究表明,在一定的剂量范围内,健康大鼠肌肉注射异种脐带间充质干细胞安全可靠,也证实了这一途径对扩张型心肌病大鼠心力衰竭同样安全有效。目的:探讨肌肉注射脐带间充质干细胞对扩张型心肌病大鼠相关细胞因子表达的影响。方法:雄性SD大鼠160只,随机抽取20只作为正常组,余大鼠通过阿霉素腹腔注射方式建立扩张型心肌病模型。造模成功大鼠随机分为模型组、上清液祖、低剂量组、中剂量组、高剂量组,分别经四肢肌肉注射人脐带间充质干细胞培养液、上清液及不同剂量的人脐带间充质干细胞,注射后观察大鼠一般情况,并于首次注射后4周再次给予相同剂量的培养液、上清液或脐带间充质干细胞。结果与结论:ELISA检测结果显示,肌注前后模型组大鼠血清肝细胞生长因子、白血病抑制因子、粒细胞集落刺激生物因子及血管内皮生长因子水平均较正常组增高(P<0.05),肌注后低剂量组肝细胞生长因子、白血病抑制因子、血管内皮生长因子和粒细胞集落刺激生物因子较肌注前显著升高(P<0.05),且较模型组明显升高(P<0.05),中剂量组白血病抑制因子较肌注前明显升高(P<0.05),高剂量组肝细胞生长因子、血管内皮生长因子和粒细胞集落刺激生物因子较肌注前无明显差异(P>0.05)。免疫组化及RT-PCR结果均显示,各肌肉注射组大鼠心肌细胞胰岛素样生长因子1、血管内皮生长因子、肝细胞生长因子均较正常组表达增强,中剂量组呈强阳性表达,较其他各组增强明显。以上结果表明中、低剂量人脐带间充质干细胞肌肉注射可使扩张型心肌病大鼠血清肝细胞生长因子、白血病抑制因子、粒细胞集落刺激生物因子及血管内皮生长因子水平增高,并增加心肌组织胰岛素样生长因子1、肝细胞生长因子、血管内皮生长因子表达。 BACKGROUND:Studies have shown that intramuscular transplantation of xenogeneic umbilical cord mesenchymal stem cel s in a certain dose range is safe and reliable, and it also confirm that this approach is equal y safe and effective for heart failure in rats with dilated cardiomyopathy. OBJECTIVE:To explore the effect of human umbilical cord mesenchymal stem cel s through intramuscular injection on the cytokine expression in adriamycin-induced dilated cardiomyopathy (DCM) rats. METHODS:Total y 160 rats were randomly divided into control group (n=20) and DCM group (n=140). Rats in the DCM group were administered adriamycin intraperitoneal y to establish DCM model. The DCM rats were randomly subdivided into model control group (served as model group), cel supernatant group, the low-dose mesenchymal stem cel group (served as low-dose group), the middle-dose mesenchymal stem cel group (served as middle-dose group), and the high-dose mesenchymal stem cel s group (served as high-dose group). Secondary injection was performed at 4 weeks after first injection. RESULTS AND CONCLUSION:The ELISA test showed that the serum levels of vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), leukemia inhibitor factor (LIF) and granulocyte macrophage colony stimulating factor (GM-CSF) were higher in the model group than the control group before and after intramuscular injection (P〈0.05). After intramuscular injection, the levels of HGF, LIF, GM-CSF and VEGF in the low-dose group were increased significantly (P〈0.05), which were significantly higher than those in the model group (P〈0.05). The level of LIF in the middle-dose group was significantly elevated after injection (P〈0.05), while there were no significant differences in HGF, VEGF and GM-CSF levels in the high-dose group before and after intramuscular injection (P〉0.05). Both the immunohistochemical and RT-PCR results showed that the expressions of insulin-like growth factor-
出处 《中国组织工程研究》 CAS 北大核心 2015年第14期2179-2185,共7页 Chinese Journal of Tissue Engineering Research
基金 青岛经济技术开发区重点科技发展计划项目(2012-2-63)~~
  • 相关文献

参考文献36

  • 1Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273(18):1450-1456. 被引量:1
  • 2Pitt B, Poole-Wilson PA, Segal R, et al. Effect of Iosartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000; 355 (9215): 1582-1587. 被引量:1
  • 3Solomon SD, Wang D, Finn P, et al. Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation. 2004; 110(15):2180-2183. 被引量:1
  • 4Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet. 2003;362(9377):7-13. 被引量:1
  • 5Dandel M, Weng Y, Siniawski H, et al. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.Circulation. 2005;112 (9 Suppl): 137-45. 被引量:1
  • 6Sun CK, Chang LT, Sheu J J, et al. Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med. 2009;37(4):1197-1205. 被引量:1
  • 7何红燕,林晓波,应文娟,林丽敏,冯学永,王鸿武,马廉.人脐带间充质干细胞经体内定植并向心肌样细胞分化的研究[J].中国输血杂志,2009,22(3):188-191. 被引量:11
  • 8林晓波,何红燕,罗敏洁,崔冰琳,冯学永,蒋学武,谢庆东,黄天华,应文娟,马廉.人脐带间充质干细胞向心肌样细胞分化的研究[J].实用儿科临床杂志,2007,22(13):971-973. 被引量:27
  • 9Noiseux N, Gnecchi M, Lopez-Ilasaca M, et al. Mesenchymal stem cells overexpressing Akt dramatically repair infarcted myocardium and improve cardiac function despite infrequent cellular fusion or differentiation. Mol Ther. 2006; 14(6):840-850. 被引量:1
  • 10杨德忠,王伟,王微,彭玉兰,黄海韵,王元元,郭燕丽,王红勇,曾春雨.旁分泌机制在脂肪间充质干细胞移植治疗心肌梗死中的作用[J].第三军医大学学报,2013,35(9):874-879. 被引量:7

二级参考文献67

共引文献44

同被引文献51

  • 1李自普,杜军保.儿童心肌病的精准诊治现状[J].中华心力衰竭和心肌病杂志(中英文),2018,2(1):57-61. 被引量:2
  • 2徐瑾,王彬尧,陈颖敏,何奔.经静脉移植骨髓间充质干细胞向扩张性心肌病大鼠心肌趋化的研究[J].心脏杂志,2007,19(3):262-265. 被引量:3
  • 3李杨,陈沅,田杰,邱俊,朱静,张小飞.心肌病大鼠骨髓间充质干细胞移植后差异表达基因cDNA文库的构建[J].中国组织工程研究与临床康复,2007,11(37):7365-7368. 被引量:2
  • 4Kawamura M,Miyagawa S,Miki K,et al.Feasibility,safety,and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.Circulation.2012;126(11 Suppl 1):S29-37. 被引量:1
  • 5Sousa MG,Paulino-Junior Dj Pascon JP,et al.Cardiac function in dogs with chronic Chagas cardiomyopathy undergoing autologous stem cell transplantation into the coronary arteries.Can Vet J.2011;52(8):869-874. 被引量:1
  • 6Tatsumi K,Otani H,Sato D,et al.Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation.Circ J.2008;72(8):1351-1358. 被引量:1
  • 7Chen Yj Liu W,Li W,et al.Autologous bone marrow mesenchymal cell transplantation improves left ventricular function in a rabbit model of dilated cardiomyopathy.Exp Mol Pathol.2010:88(2):311-315. 被引量:1
  • 8Quevedo HC,Hatzistergos KE,Oskouei BNf et al.Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity.Proc Natl Acad Sci U SA.2009;106(33):14022-14027. 被引量:1
  • 9Templin C,Luscher TF,Landmesser U.Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.Int J Dev Biol.2011;55(4-5):407-417. 被引量:1
  • 10Skou AS,Tranebjaerg L,Jensen Tj et al.Mitochondrial 12S ribosomal RNAA1555G mutation associated with cardiomyopathy and hearing loss following high-dose chemotherapy and repeated aminoglycoside exposure.J Pediatr.2014;164(2):413-415. 被引量:1

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部